WealthPlan Investment Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.87M Buy
257,710
+2,222
+0.9% +$27K 0.14% 130
2026
Q1
$3.57M Buy
255,488
+174,506
+215% +$2.45M 0.2% 110
2025
Q4
$1.17M Buy
+80,982
New +$1.22M 0.07% 185

Other funds holding BTAL

WealthPlan Investment Management's BTAL Position: Q2 2026 in Review

WealthPlan Investment Management increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 0.87% in Q2 2026, buying an estimated $27K and bringing the position to 257,710 shares worth $2.87M. The position accounts for 0.14% of the portfolio, ranked #130.

WealthPlan Investment Management first reported a position in BTAL in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.57M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • WealthPlan Investment Management held 257,710 shares of AGF US Market Neutral Anti-Beta Fund worth $2.87M as of Q2 2026.
  • WealthPlan Investment Management bought 2,222 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $27K.
  • AGF US Market Neutral Anti-Beta Fund made up 0.14% of WealthPlan Investment Management's portfolio in Q2 2026, its #130 holding.
  • WealthPlan Investment Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2025 and has held it in 3 quarters since.
  • WealthPlan Investment Management's AGF US Market Neutral Anti-Beta Fund position peaked at $3.57M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on WealthPlan Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.